A collection of links to stories and articles concerning melanoma and skin cancer:
Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022
BRAF/MEK Inhibitor Combination Therapy Will Become Treatment of Choice for BRAF-Mutation-Positive Unresectable Malignant Melanoma, According to a New Report from Decision Resources
Source: MarketWatch
Registry offers insights into pediatric melanoma outcomes
Tumor thickness, lymph node status, ulceration and disease stage significantly predicted survival among pediatric patients with melanoma, according to results of a retrospective review.
Source: Healio
Melanoma patients may benefit from electroporation
Once it spreads, this type of skin cancer is extremely difficult to treat. But now researchers say a new therapy is helping them shock away some of the most stubborn tumors.
Source: ABC
Seemingly pan-negative melanomas may be sensitive to MEK inhibitor
A small subset of patients with supposedly nongenetically driven melanomas respond to molecularly targeted treatment with an MEK inhibitor, according to recent findings released today.
Source: Oncology Practice
Colchester Hospital: NHS England probe finds five cancer areas 'unsafe'
NHS England found five areas - including skin cancer and urology - were unsafe. The hospital said the main issues found were with the "processes".
Source: BBC
Tests begin on skin cancer detection website
A team of dermatologists is beta testing a website designed as a tool to provide early detection of skin cancer.
Source: Dermatology Times
Another UCLA stem cell breakthrough on skin cancer
Investigators at UCLA’s Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have discovered how tissue-specific hair follicle stem cells promote the development of squamous cell skin cancer. They note that understanding the mechanism of stem cell cancer suppression could lead to the development of preventive measures for individuals susceptible to squamous skin cancer. The study was published online on December 15 in the journal Nature Cell Biology.
Source: Examiner
Vancouver skin cancer detection device ready for market; Nobel Prize-winning research behind it
Is a real-time skin-cancer detector a suitable substitute — or a solid second opinion — for dermatologists, since such specialized doctors are in such short supply around the world? And will B.C. patients with worrisome lesions ever even benefit from the BC Cancer Agency/University of B.C.-patented device?
Source: Vancouver Times
Skin cancer breakthrough to be developed in Brisbane
A strategic partnership between The University of Queensland and global pharmaceutical company LEO Pharma will investigate the genetic causes of squamous cell carcinoma, the world’s second most common skin cancer.
Source: University of Queensland
No comments:
Post a Comment